Advancing quality. Enriching lives.

Hiba Pharma
Hiba Pharma

Excellence in Oncology Pharmaceutical Manufacturing

At Hiba Pharma, we are committed to excellence in oncology pharmaceutical manufacturing.

Through cutting-edge technology we develop life-saving cancer treatments that improve patient outcomes.

Our mission is clear: to advance pharmaceutical quality and enrich lives by providing safe, effective, and reliable therapies for those who need them most.

Scientist working in an oncology laboratory
Hiba flag
Dr. Hiba Jaber
“Our vision is simple: make high-quality healthcare more accessible through innovation, standards, and a commitment to every person.”

Dr. HIBA JABER

CEO

Engineers reviewing facility drawings on siteHiba Pharma team at workWorkstations in the new production areaQuality control laboratory benchesCorridor between the production suites

Portfolio

HIBA Pharma is dedicated to provide high-quality pharmaceutical solutions that address critical healthcare challenges. Our diverse product portfolio spans multiple therapeutic categories that include but not limited to:

Oncology

Oncology injectables

ProductStrengthFormulation type
Carboplatin 10mg/mL Solution for Infusion
Strength150mg/15mL, 450mg/45mL
Formulation typeLiquid Vials
Oxaliplatin 5mg/mL Solution for Injection
Strength50mg/10mL, 100mg/20mL
Formulation typeLiquid Vials
Pemetrexed 500mg Powder for Concentrate for Solution for Infusion
Strength500 mg/Vial
Formulation typeLyophilised
Irinotecan HCl 20mg/mL Concentrate For Solution For Infusion
Strength40mg/2mL, 100mg/5mL, 300mg/15mL
Formulation typeLiquid Vials
Gemcitabine Powder For Solution For Infusion
Strength200mg/Vial, 1000mg/Vial
Formulation typeLyophilised
Docetaxel 20mg/mL Concentrate Solution For Infusion
Strength20mg/1mL, 80mg/4mL
Formulation typeLiquid Vials
Paclitaxel 6mg/mL Concentrate For Solution For Infusion
Strength30mg/5mL, 100mg/16.7mL, 150mg/25mL, 300mg/50mL
Formulation typeLiquid Vials
Methotrexate 2.5 mg/mL solution for injection
Strength5mg/2mL, 50mg/2mL
Formulation typeLiquid Vials
Fluorouracil 50mg/mL Solution For Injection
Strength250mg/5mL, 500mg/10mL, 1000mg/20mL, 5000mg/100mL
Formulation typeLiquid Vials
Folinic Acid 10 mg/ml solution for injection
Strength5ml, 10ml, 20ml, 50ml, 100ml
Formulation typeLiquid Vials
Zoledronic 4 mg/5 ml concentrate for solution for infusion
Strength5ml
Formulation typeLiquid Vials

Oncology oral solids

ProductStrengthFormulation type
Abiraterone
Strength250mg, 500mg
Formulation typeTablets
Capecitabine
Strength150mg, 500mg
Formulation typeTablets
Erlotinib
Strength100mg, 150mg
Formulation typeTablets
Everolimus
Strength2.5mg, 5mg, 7.5mg, 10mg
Formulation typeTablets
Gefitinib
Strength250mg
Formulation typeTablets
Imatinib
Strength100mg, 400mg
Formulation typeTablets
Lenalidomide
Strength2.5mg, 5mg, 10mg, 15mg, 20mg, 25mg
Formulation typeCapsules
Nilotinib
Strength50mg, 150mg, 200mg
Formulation typeCapsules
Pazopanib
Strength200mg, 400mg
Formulation typeTablets
Sunitinib
Strength12.5mg, 25mg, 37.5mg, 50mg
Formulation typeCapsules
Leflunomide
Strength10mg, 20mg
Formulation typeTablets
Tofacitinib
Strength5mg
Formulation typeTablets
Metabolic Disorders

Metabolic disorders

ProductStrengthFormulation type
Dapagliflozin
Strength10mg
Formulation typeTablet
Gliclazide MR
Strength30mg, 60mg
Formulation typeMR Tablet
Linagliptin
Strength5mg
Formulation typeTablet
Sitagliptin
Strength50mg, 100mg
Formulation typeTablet
Sitagliptin/Metformin
Strength50/500mg, 50/850mg, 50/1000mg
Formulation typeTablet
Deferasirox IR
Strength90mg, 180mg, 360mg
Formulation typeTablet
Deferiprone
Strength500mg
Formulation typeTablet
Febuxostat
Strength40mg, 80mg
Formulation typeTablet
Sevelamer Carbonate
Strength800mg
Formulation typeTablet
Cardiology

Cardiology

ProductStrengthFormulation type
Amlodipine/Telmisartan
Strength5/40mg, 5/80mg, 10/40mg, 10/80mg
Formulation typeBilayer Tablet
Amlodipine/Valsartan
Strength5/80mg, 5/160mg, 10/160mg
Formulation typeTablet
Apixaban
Strength2.5mg, 5mg
Formulation typeTablet
Atorvastatin/Ezetimibe
Strength10/10mg, 20/10mg, 40/10mg
Formulation typeBilayer Tablet
Dabigatran Etexilate
Strength75mg, 110mg, 150mg
Formulation typeCapsule
Midodrine
Strength2.5mg, 5mg, 10mg
Formulation typeTablet
Rivaroxaban
Strength10mg, 15mg, 20mg
Formulation typeTablet
Rosuvastatin
Strength5mg, 10mg, 20mg
Formulation typeTablet
Sacubitril/Valsartan
Strength24/26mg, 49/51mg, 97/103mg
Formulation typeTablet
Telmisartan
Strength40mg, 80mg
Formulation typeTablet
GIT Disorders

GIT disorders

ProductStrengthFormulation type
Vonoprazan
Strength10mg, 20mg
Formulation typeTablet
Entecavir
Strength0.5mg
Formulation typeTablet
Hematology

Hematology

ProductStrengthFormulation type
Deferasirox IR
Strength90mg, 180mg, 360mg
Formulation typeTablet
Deferiprone
Strength500mg
Formulation typeTablet
Immunology

Immunology

ProductStrengthFormulation type
Etoricoxib
Strength60mg, 90mg, 120mg
Formulation typeTablet
Mycophenolic Acid
Strength180mg, 360mg
Formulation typeDR Tablet
Mycophenolate Mofetil
Strength250mg, 500mg
Formulation typeTablet
Urological Disorders

Urological disorders

ProductStrengthFormulation type
Solifenacin
Strength5mg, 10mg
Formulation typeTablet
Tadalafil
Strength5mg, 20mg
Formulation typeTablet
Tamsulosin OCAS
Strength0.4mg
Formulation typeOCAS Tablet
Hiba Pharma facility corridor

HIBA Pharma takes pride in operating state-of-the-art manufacturing facility in Kezad, Abu Dhabi, UAE, equipped with the latest industry technologies.

Facility

Our facility is being built to comply with cGMP regulations and international standards, ensuring the highest safety, efficacy, and quality standards in every product we manufacture. We are proud to be the only local facility producing sterile injectable oncology medications. We stand at the forefront of pharmaceutical advancements, reinforcing our commitment to addressing unmet medical needs.

Packaging

100

million packs per year

Capacity

1.5

billion tablets per year

0.25

billion capsules per year

40

million vials per year

Laboratory at Hiba Pharma

Size

Our facility is being built to comply with cGMP regulations and international standards, ensuring the highest safety, efficacy, and quality standards in every product we manufacture.

16 000

current area, m2

Hiba Pharma laboratory

HIBA PHARMA actively seeks partnerships with forward-thinking pharmaceutical firms that share our commitment to innovation, quality, and patient-centric approach through Licensing, Technology Transfer and Contract Manufacturing